Radiation Therapy After Mastectomy: Mistaken Assumptions

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 12
Volume 9
Issue 12

I am writing in reference to your “Oncology Rounds” section in the September 2000 issue of Oncology News International (page 18). In the first case, entitled “What further therapy for this woman postmastectomy?” I noted that in the answer given by I. Craig Henderson, MD, there was no specific mention of adjuvant radiation therapy.

I am writing in reference to your “Oncology Rounds” section in the September 2000 issue of Oncology News International (page 18). In the first case, entitled “What further therapy for this woman postmastectomy?” I noted that in the answer given by I. Craig Henderson, MD, there was no specific mention of adjuvant radiation therapy.

This patient had inflammatory breast cancer by definition with dermal lymphatic involvement and, in addition, on mastectomy had positive margins on the chest wall.

Although I would agree with Dr. Henderson that she should be treated with aggressive systemic therapy, she is also at high risk for locoregional recurrence and should be treated with post-mastectomy radiation.

I do agree with Dr. Henderson’s comments that upfront chemotherapy followed by “local treatment” (mastectomy and then adjuvant radiation therapy) would have been the optimal treatment sequence.

GABRIELA B. MASKO, MD
Radiation Oncology Associates, Inc.Providence, Rhode Island

In the September ONI “Oncology Rounds,” a reader asked about further treatment for a woman after mastectomy. Clearly, this woman has inflammatory breast cancer, and while I would agree with Dr. I. Craig Henderson’s approach with chemotherapy preoperatively, I do not understand his omission of the need for radiation therapy after her chemotherapy and surgery is complete.

This patient has a positive margin and dermal lymphatic invasion, and has a very high likelihood of local recurrence and requires trimodality therapy.

Please clarify this issue with Dr. Henderson. From a medical oncology standpoint, I am afraid readers will assume that chemotherapy is the only adjuvant treatment this patient will need. Without question, she needs radiation therapy as well.

ANITA JOY HILLIARD, MD
Radiation Oncology Associates of Lynchburg, Inc.Lynchburg, Virginia

Dr. Henderson Replies:

In my discussion of this case in “Oncology Rounds,” I referred to “local treatment,” stating that “many, if not most, oncologists would have treated this patient with chemotherapy before administering local treatment.” Dr. Hilliard assumed I meant mastectomy when referring to “local treatment.” Dr. Masko assumed I meant both mastectomy and adjuvant radiation therapy.

In actual practice, I always administer radiation therapy to a patient with inflammatory breast cancer. I do not always recommend mastectomy. This will depend on the completeness of the patient’s response to chemotherapy and radiation therapy.

I have a few patients who were treated with chemotherapy and radiation therapy only who are alive and free of disease for periods in excess of 10 years.

I. CRAIG HENDERSON, MD
Adjunct Professor of MedicineUniversity of California San Francisco, California

Related Videos
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Patient-reported symptoms following surgery appear to improve with the use of perioperative telemonitoring, says Kelly M. Mahuron, MD.
Treatment options in the refractory setting must improve for patients with resected colorectal cancer peritoneal metastasis, says Muhammad Talha Waheed, MD.
Karine Tawagi, MD, and Sia Daneshmand, MD, with the Oncology Brothers presenting slides
Karine Tawagi, MD, and Sia Daneshmand, MD, with the Oncology Brothers presenting slides
Karine Tawagi, MD, and Sia Daneshmand, MD, with the Oncology Brothers presenting slides
Karine Tawagi, MD, and Sia Daneshmand, MD, with the Oncology Brothers presenting slides
Related Content